Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy
2017-01-01 Monforte, Ad; Antinori, A; Cozzi-Lepri, A; Ceccherini-Silberstein, F; Castagna, A; Caputo, Sl; Mussini, C; De Luca, A; Madeddu, G; Cingolani, A; Tavelli, A; Taliani, G; Gori, A; Girardi, E; Puoti, M
Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects
2017-01-01 Merli, M; Galli, L; Poli, A; Salpietro, S; Messina, E; Parisi, Mr; Andolina, A; Morsica, G; Bagaglio, S; Castagna, A; Lazzarin, A; Uberti-Foppa, C; Hasson, H
LONG TERM CD4 RECOVERY IN FULLY SUPPRESSED SUBJECTS TREATED WITH FIRST LINE HAART IS INFLUENCED BY TIME TO REACH UNDETECTABILITY
2011-01-01 Travi, G; Salpietro, S; Pizzocolo, C; Galli, L; Spagnuolo, V; Cossarini, F; Gianotti, N; Nozza, S; Lazzarin, A; Castagna, A
The potential impact of splenectomy in treatment of visceral Leishmaniasis in a multi-experienced HIV-coinfected patient
2017-01-01 Chiappetta, S; Guffanti, M; Cernuschi, M; Bossolasco, S; Maillard, M; Ceserani, N; Boeri, E; Racca, S; Castagna, A; Gaiera, G
Incidence, Temporal Trends, and Predictors of Thrombocytopenia Among HIV-Infected Persons Treated with Combined Antiretroviral Therapy (cART)
2010-01-01 Bibas, M; Trotta, Mp; Lorenzini, P; Cozzi-Lepri, A; Castagna, A; De Luca, A; Mussini, C; Puoti, M; Monforte, Ad; Antinori, A
Genotype 3 Infection in HIV/HCV co-infected subjects in the DAA era: Real life data from the ICONA/HepaICONA Foundation cohorts
2018-01-01 Rossotti, R.; Lorenzini, P.; Merli, M.; Castagna, A.; De Luca, A.; Antinori, A.; Chiamenti, M.; Mastrorosa, I.; Verucchi, G.; Maggiolo, F.; Monforte, A. D.; Puoti, M.
Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine
2010-01-01 Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A
Immune Reconstitution is Associated with Delayed Occurrence and Longer Survival after Hodgkin Disease in HIV-infected Patients
2010-01-01 Cossarini, F; Galli, L; Spagnolo, V; Sampietro, S; Travi, G; Bossolasco, S; Gianotti, N; Cinque, P; Lazzarin, A; Castagna, A
Lymphoma occurrence does not impair long term CD4 recovery in HIV plus cancer survivors
2010-01-01 Travi, G; Galli, L; Spagnolo, V; Cossarini, F; Gianotti, N; Cinque, P; Bossolasco, S; Salpietro, S; Bigoloni, A; Lazzarin, A; Castagna, A
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes
2018-01-01 Rinaldi, F; Rolla, S; Galli, L; Andrea, P; Bigoloni, A; Muccini, C; Mastrangelo, A; Nozza, S; Tavano, C; Clementi, M; Lazzarin, A; Bartoloni, A; Castagna, A
Role of Microbial Translocation (MT) and Immune Hyperactivation (IH) in Liver Disease Progression of HIV/HCV plus Patients with well documented HIV seroconversion date and preserved CD4 count
2010-01-01 Cozzi-Lepri, Gma; Bellistri, Gm; Merlini, E; Leoncini, F; Baldelli, F; Antonucci, G; Castagna, A; Raise, E; Manzini, L; Manconi, Pe; Puoti, M; De Luca, A; Monforte, Ad
Use of integrase strand transfer inhibitors (INSTIs) in a cohort of HIV-infected geriatric patients (GEPPO cohort)
2018-01-01 Nozza, S; Calza, S; Guaraldi, G; Gervasi, E; Riva, A; De Socio, G; Piconi, S; Orofino, G; Castagna, A; Di Perri, G; Cattelan, A; Magro, P; Celesia, B; Calcagno, A; Foca, E
Long-term suppression of viral replication in HIV-related lymphoma survivors: a case-control study
2010-01-01 Spagnuolo, V; Galli, L; Travi, G; Cossarini, F; Salpietro, S; Gianotti, N; Cinque, P; Bossolasco, S; Vinci, C; Lazzarin, A; Castagna, A
PHARMACOKINETICS AND PHARMACOGENETICS OF MARAVIROC IN THE CLINICAL SETTING
2009-01-01 Siccardi, M; Bonora, S; Nozza, S; Castagna, A; D'Avolio, A; Michelazzo, M; Chiesa, M; Calcagno, A; Lazzarin, A; Di Perri, G
Effectiveness and safety of cobicistat-boosted darunavir-based antiretroviral treatment in an Italian observational cohort: the TMC114FD1HTX4003 (STORE.) study
2018-01-01 Gori, A; Antinori, A; Ripamonti, D; Rusconi, S; Gianotti, N; Maserati, R; Muscatello, A; Di Cristo, V; Castagna, A; Rizzardini, G; Cattelan, A; Menzaghi, B; Sterrantino, G; Kiros, S; Castelli, F; Foca, E; Saccani, B; Orofino, G; Farenga, M; Cauda, R; La Monica, S; Vullo, V; De Luca, A; Rossetti, B; Manzillo, E; Gioe, C; Celesia, B; Locatelli, M; Madeddu, G; Bagella, P; Santantonio, T; Ferrara, S; Cosco, L; Pontali, E; Monforte, Ad; Curetti, R; Andreoni, M; Stingone, C; Uglietti, A; Termini, R; Mancusi, D
LONG-TERM SURVIVAL AMONG HIV-1 INFECTED PATIENTS WITH AIDS AND NON AIDS RELATED MALIGNANCIES
2009-01-01 Spagnuolo, V; Galli, L; Salpietro, S; Bigoloni, A; Cinque, P; Gianotti, N; Bossolasco, S; Guffanti, M; Fumagalli, L; Lazzarin, A; Castagna, A
Incidence of dyslipidaemia and modification of atherosclerotic cardiovascular disease (ASCVD) risk in HIV-infected patients who switch away from tenofovir disoproxil fumarate (TDF)-based to TDF-sparing regimens in the Icona Foundation Cohort
2018-01-01 Cicalini, S; Lorenzini, P; Cozzi-Lepri, A; Maggiolo, F; Gianotti, N; Rusconi, S; Lapadula, G; Cirioni, O; Castagna, A; Mussini, C; Lo Caputo, S; Antinori, A
PHENOTYPIC PROFILES OF HIV-1 INTEGRASE GENE EVOLUTION DURING RALTEGRAVIR FAILURE
2009-01-01 Canducci, F; Marinozzi, Mc; Sampaolo, M; Boeri, E; Castagna, A; Gianotti, N; Spagnuolo, V; Baldanti, F; Paolucci, S; Gulminetti, R; Lazzarin, A; Clementi, M
Analysis of impediments to the maintenance in care of people with HIV in Italy
2018-01-01 Battistella, A; Errico, M; Rossetti, B; Pontali, E; Bassetti, M; Lichtner, M; Rizzi, M; Manfrin, V; Gori, A; Celesia, B; Viscoli, C; Comelli, A; Angarano, G; Lazzarin, A; Castagna, A; Borgia, G; Menzaghi, B; Nunnari, G; Corsini, R; Calza, L; Vichi, F; Sulekova, Lf; Giannetti, A; Magnani, G; Monforte, Ad; Iardino, M; Rizzardini, G
DEVELOPMENT OF ALLELE-SPECIFIC PCR (AS-PCR) ASSAYS TO INVESTIGATE MAJOR HIV RESISTANCE MUTATIONS TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) AND NON NUCLEOSIDE RT INHIBITORS (NNRTI)
2009-01-01 Formicola, R; Bestetti, A; Soria, A; Galli, L; Danise, A; Sala, S; Sampaolo, M; Galli, A; Gianotti, N; Clementi, M; Lazzarin, A; Castagna, A; Cinque, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy | 1-gen-2017 | Monforte, Ad; Antinori, A; Cozzi-Lepri, A; Ceccherini-Silberstein, F; Castagna, A; Caputo, Sl; Mussini, C; De Luca, A; Madeddu, G; Cingolani, A; Tavelli, A; Taliani, G; Gori, A; Girardi, E; Puoti, M | |
| Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects | 1-gen-2017 | Merli, M; Galli, L; Poli, A; Salpietro, S; Messina, E; Parisi, Mr; Andolina, A; Morsica, G; Bagaglio, S; Castagna, A; Lazzarin, A; Uberti-Foppa, C; Hasson, H | |
| LONG TERM CD4 RECOVERY IN FULLY SUPPRESSED SUBJECTS TREATED WITH FIRST LINE HAART IS INFLUENCED BY TIME TO REACH UNDETECTABILITY | 1-gen-2011 | Travi, G; Salpietro, S; Pizzocolo, C; Galli, L; Spagnuolo, V; Cossarini, F; Gianotti, N; Nozza, S; Lazzarin, A; Castagna, A | |
| The potential impact of splenectomy in treatment of visceral Leishmaniasis in a multi-experienced HIV-coinfected patient | 1-gen-2017 | Chiappetta, S; Guffanti, M; Cernuschi, M; Bossolasco, S; Maillard, M; Ceserani, N; Boeri, E; Racca, S; Castagna, A; Gaiera, G | |
| Incidence, Temporal Trends, and Predictors of Thrombocytopenia Among HIV-Infected Persons Treated with Combined Antiretroviral Therapy (cART) | 1-gen-2010 | Bibas, M; Trotta, Mp; Lorenzini, P; Cozzi-Lepri, A; Castagna, A; De Luca, A; Mussini, C; Puoti, M; Monforte, Ad; Antinori, A | |
| Genotype 3 Infection in HIV/HCV co-infected subjects in the DAA era: Real life data from the ICONA/HepaICONA Foundation cohorts | 1-gen-2018 | Rossotti, R.; Lorenzini, P.; Merli, M.; Castagna, A.; De Luca, A.; Antinori, A.; Chiamenti, M.; Mastrorosa, I.; Verucchi, G.; Maggiolo, F.; Monforte, A. D.; Puoti, M. | |
| Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine | 1-gen-2010 | Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A | |
| Immune Reconstitution is Associated with Delayed Occurrence and Longer Survival after Hodgkin Disease in HIV-infected Patients | 1-gen-2010 | Cossarini, F; Galli, L; Spagnolo, V; Sampietro, S; Travi, G; Bossolasco, S; Gianotti, N; Cinque, P; Lazzarin, A; Castagna, A | |
| Lymphoma occurrence does not impair long term CD4 recovery in HIV plus cancer survivors | 1-gen-2010 | Travi, G; Galli, L; Spagnolo, V; Cossarini, F; Gianotti, N; Cinque, P; Bossolasco, S; Salpietro, S; Bigoloni, A; Lazzarin, A; Castagna, A | |
| Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes | 1-gen-2018 | Rinaldi, F; Rolla, S; Galli, L; Andrea, P; Bigoloni, A; Muccini, C; Mastrangelo, A; Nozza, S; Tavano, C; Clementi, M; Lazzarin, A; Bartoloni, A; Castagna, A | |
| Role of Microbial Translocation (MT) and Immune Hyperactivation (IH) in Liver Disease Progression of HIV/HCV plus Patients with well documented HIV seroconversion date and preserved CD4 count | 1-gen-2010 | Cozzi-Lepri, Gma; Bellistri, Gm; Merlini, E; Leoncini, F; Baldelli, F; Antonucci, G; Castagna, A; Raise, E; Manzini, L; Manconi, Pe; Puoti, M; De Luca, A; Monforte, Ad | |
| Use of integrase strand transfer inhibitors (INSTIs) in a cohort of HIV-infected geriatric patients (GEPPO cohort) | 1-gen-2018 | Nozza, S; Calza, S; Guaraldi, G; Gervasi, E; Riva, A; De Socio, G; Piconi, S; Orofino, G; Castagna, A; Di Perri, G; Cattelan, A; Magro, P; Celesia, B; Calcagno, A; Foca, E | |
| Long-term suppression of viral replication in HIV-related lymphoma survivors: a case-control study | 1-gen-2010 | Spagnuolo, V; Galli, L; Travi, G; Cossarini, F; Salpietro, S; Gianotti, N; Cinque, P; Bossolasco, S; Vinci, C; Lazzarin, A; Castagna, A | |
| PHARMACOKINETICS AND PHARMACOGENETICS OF MARAVIROC IN THE CLINICAL SETTING | 1-gen-2009 | Siccardi, M; Bonora, S; Nozza, S; Castagna, A; D'Avolio, A; Michelazzo, M; Chiesa, M; Calcagno, A; Lazzarin, A; Di Perri, G | |
| Effectiveness and safety of cobicistat-boosted darunavir-based antiretroviral treatment in an Italian observational cohort: the TMC114FD1HTX4003 (STORE.) study | 1-gen-2018 | Gori, A; Antinori, A; Ripamonti, D; Rusconi, S; Gianotti, N; Maserati, R; Muscatello, A; Di Cristo, V; Castagna, A; Rizzardini, G; Cattelan, A; Menzaghi, B; Sterrantino, G; Kiros, S; Castelli, F; Foca, E; Saccani, B; Orofino, G; Farenga, M; Cauda, R; La Monica, S; Vullo, V; De Luca, A; Rossetti, B; Manzillo, E; Gioe, C; Celesia, B; Locatelli, M; Madeddu, G; Bagella, P; Santantonio, T; Ferrara, S; Cosco, L; Pontali, E; Monforte, Ad; Curetti, R; Andreoni, M; Stingone, C; Uglietti, A; Termini, R; Mancusi, D | |
| LONG-TERM SURVIVAL AMONG HIV-1 INFECTED PATIENTS WITH AIDS AND NON AIDS RELATED MALIGNANCIES | 1-gen-2009 | Spagnuolo, V; Galli, L; Salpietro, S; Bigoloni, A; Cinque, P; Gianotti, N; Bossolasco, S; Guffanti, M; Fumagalli, L; Lazzarin, A; Castagna, A | |
| Incidence of dyslipidaemia and modification of atherosclerotic cardiovascular disease (ASCVD) risk in HIV-infected patients who switch away from tenofovir disoproxil fumarate (TDF)-based to TDF-sparing regimens in the Icona Foundation Cohort | 1-gen-2018 | Cicalini, S; Lorenzini, P; Cozzi-Lepri, A; Maggiolo, F; Gianotti, N; Rusconi, S; Lapadula, G; Cirioni, O; Castagna, A; Mussini, C; Lo Caputo, S; Antinori, A | |
| PHENOTYPIC PROFILES OF HIV-1 INTEGRASE GENE EVOLUTION DURING RALTEGRAVIR FAILURE | 1-gen-2009 | Canducci, F; Marinozzi, Mc; Sampaolo, M; Boeri, E; Castagna, A; Gianotti, N; Spagnuolo, V; Baldanti, F; Paolucci, S; Gulminetti, R; Lazzarin, A; Clementi, M | |
| Analysis of impediments to the maintenance in care of people with HIV in Italy | 1-gen-2018 | Battistella, A; Errico, M; Rossetti, B; Pontali, E; Bassetti, M; Lichtner, M; Rizzi, M; Manfrin, V; Gori, A; Celesia, B; Viscoli, C; Comelli, A; Angarano, G; Lazzarin, A; Castagna, A; Borgia, G; Menzaghi, B; Nunnari, G; Corsini, R; Calza, L; Vichi, F; Sulekova, Lf; Giannetti, A; Magnani, G; Monforte, Ad; Iardino, M; Rizzardini, G | |
| DEVELOPMENT OF ALLELE-SPECIFIC PCR (AS-PCR) ASSAYS TO INVESTIGATE MAJOR HIV RESISTANCE MUTATIONS TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) AND NON NUCLEOSIDE RT INHIBITORS (NNRTI) | 1-gen-2009 | Formicola, R; Bestetti, A; Soria, A; Galli, L; Danise, A; Sala, S; Sampaolo, M; Galli, A; Gianotti, N; Clementi, M; Lazzarin, A; Castagna, A; Cinque, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista3192
Data di pubblicazione
- In corso di stampa1
- 2020 - 202596
- 2010 - 20191464
- 2000 - 20091294
- 1990 - 1999321
- 1983 - 198916
Editore
- ELSEVIER22
- LIPPINCOTT WILLIAMS & WILKINS14
- NLM (Medline)13
- URBAN & VOGEL12
- ELSEVIER SCIENCE BV11
- DR DIETRICH STEINKOPFF VERLAG10
- ELSEVIER SCIENCE INC10
- OXFORD UNIV PRESS10
- SPRINGER HEIDELBERG10
- SPRINGER9
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS174
- JOURNAL OF NEUROLOGY153
- THE JOURNAL OF UROLOGY152
- BONE MARROW TRANSPLANTATION127
- EUROPEAN NEUROPSYCHOPHARMACOLOGY126
- NEUROLOGICAL SCIENCES88
- BLOOD86
- EUROPEAN HEART JOURNAL72
- NEUROLOGY72
- GASTROENTEROLOGY71
Keyword
- systemic sclerosis12
- Children4
- fibrosis4
- JIA4
- JSLE4
- None4
- angiogenesis3
- animal model3
- Bone mass3
- IPMN3
Lingua
- eng1301
- ita202
- und13
Accesso al fulltext
- no fulltext3161
- reserved25
- open6